Replies to post #88170 on Bots Inc (BTZI)

[lesgetrich]

LMAO People in glass houses shouldn't throw stones. I never predicted $80 million in OMHE revenue. It was posed as a contradiction/question in one of my blog posts...

Four Long Term Penny Stock Picks For A Profitable 2017

On October 24, well before the Omni announcement, Paul Rosenberg stated...

"Omni Health, Inc. -- While not recorded on the financial statements of MCIG, the Company maintains approximately a 9% interest in the company. Omni Health is the manufacturer and distributor of anti-aging creams and operates a Pharmacy operation in the Miami, Florida area.

Omni Health is conservatively projecting $6M in revenue with an 8% net profit margin for FY 2017. Omni will be more active independently promoting their company as soon as the symbol change is approved, any day now. Realizing value for our shareholders is a must and we have great plans for our position in Omni for our shareholders."



At this point, I have not been able to track down any information on the anti aging creams, or how much revenue or profit that part of the business represents. However, the $6 million in revenue seems to conflict with the $1.6 million net income and 8% profit margin. Even if one factors in the lost profit from VitaCig discontinued operations, it would only contribute a small fraction of the $1.6 million in net income. An 8% profit margin with $1.6 million in earnings should put their revenue at roughly $20,000,000/quarter or $80,000,000/year.

So what do we know?

1.) Fact - Omni has reported that Their Net Income (earnings) for 1FQ2017 was $1.6 million

2.) Fact - Their current shares outstanding is 1,130,651,683 as of November 7.

3.) Fact - That makes their Earnings per Share $.00566/share if projected over 4 quarters.

4.) Fact - That makes Omni's current Price Earnings (NYSE:PE) ratio (at a pps of $.025/share) 4.42

5.) Fact - Average PE ratios for companies in the Healthcare and Drug sectors range from 32.11 to 66.58

6.) Fact - If Omni's PE were to conform to the sector averages, it's pps would be $.18 to $.38/share

7.) Fact - mCig reported that Omni's profit margin was 8%. That translates to $20 million in revenue for 1FQ17 or $80 million over 4 quarters.

Even at a very conservative PE ratio of 10x, this stock would be trading at $.0566/share. It closed last Friday at $.025.

So we're left with several questions.

Was the $1.6 million in net income for 1FQ17 an anomaly or is it representative of what we can expect each quarter?

What should we make of Paul Rosenberg's projection of $6 million in annual revenue for 2017 with an 8% profit margin? Was he being conservative, acting on dated information or has LX Retail added an additional business unit to the company or done an acquisition?

How much of this company's profits are driven by the specialty pharmacy business and how much is being contributed by anti-aging creams?

What are Omni's plans for growth and expansion? Why did they decide to go public now?

Once Omni draws back the curtain and answers these questions I expect we'll see a very profitable pop in its share price.

Another phony claim - Debunked Again